Xiao Lan Yang
Direktor/Vorstandsmitglied bei Shanghai Genext Medical Technology Co., Ltd.
Profil
Xiao Lan Yang is currently the Director & Deputy General Manager at Shanghai Genext Medical Technology Co., Ltd.
She started this position in 2020.
Prior to her current role, she has a background in education.
She graduated from the University of Lyon and obtained an undergraduate degree from Shanghai Medical College of Fudan University.
She also holds an MBA from Olin Business School and Fudan University School of Management.
Aktive Positionen von Xiao Lan Yang
Unternehmen | Position | Beginn |
---|---|---|
Shanghai Genext Medical Technology Co., Ltd.
Shanghai Genext Medical Technology Co., Ltd. Medical SpecialtiesHealth Technology Shanghai Genext Medical Technology Co., Ltd. provides medical device products and services in the field of organ transplantation. It mainly supplies equipment for organ preservation, transportation, evaluation, and repair; medical consumables; and personalized diagnostic reagents for transplant patients. The company was founded on March 25, 2003 and is headquartered in Shanghai, China. | Direktor/Vorstandsmitglied | 01.04.2020 |
Ausbildung von Xiao Lan Yang
Shanghai Medical College of Fudan University | Undergraduate Degree |
University of Lyon | Graduate Degree |
Fudan University School of Management | Masters Business Admin |
Olin Business School | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Shanghai Genext Medical Technology Co., Ltd.
Shanghai Genext Medical Technology Co., Ltd. Medical SpecialtiesHealth Technology Shanghai Genext Medical Technology Co., Ltd. provides medical device products and services in the field of organ transplantation. It mainly supplies equipment for organ preservation, transportation, evaluation, and repair; medical consumables; and personalized diagnostic reagents for transplant patients. The company was founded on March 25, 2003 and is headquartered in Shanghai, China. | Health Technology |